Partner Headlines - GEVA

  1. Synageva BioPharma Completes Rolling Submission Of Biologics ...

    Benzinga
  2. Synageva BioPharma Presents Sebelipase Alfa Data At The NASPGHAN ...

    Benzinga
  3. Synageva Shares Tumble Amid Positive Phase 3 Data, A Director's ...

    Benzinga
  4. Acuity Brands Drops On Downbeat Results; GoPro Shares Surge

    Benzinga
  5. Mid-Day Market Update: Acuity Brands Drops On Downbeat Results; ...

    Benzinga
  6. Markets Surge; GM June Sales Rise 1%

    Benzinga
  7. Morning Market Losers

    Benzinga
  8. SYNAGEVA BIOPHARMA

    IBD
  9. Synageva BioPharma Reports Phase 3 Study Meets Primary Endpoint ...

    Benzinga
  10. UPDATE: Morgan Stanley Reiterates on Synageva BioPharma as Brain-Blood ...

    Benzinga
  11. UPDATE: Synageva Biopharma™ Announces 2M Share Proposed Public ...

    Benzinga
  12. Synageva BioPharma Completes Target Enrollment in Phase 3 ARISE ...

    Benzinga
  13. Benzinga's Top Initiations

    Benzinga
  14. UPDATE: Goldman Sachs initiates on Synageva Following Positive ...

    Benzinga
  15. UPDATE: Leerink Swann Downgrades Synageva BioPharma Corp. on ...

    Benzinga
  16. UPDATE: Wedbush Downgrades Synageva BioPharma on Valuation

    Benzinga
  17. Benzinga's Volume Movers

    Benzinga
  18. Synageva BioPharma Prices 2.75M Share Offering at $56.63/Share

    Benzinga
  19. Synageva BioPharma Corp (GEVA) SVP, CFO Carsten Boess sells 9,927 ...

    GuruFocus
  20. UPDATE: Piper Jaffray Reiterates Neutral Rating, Lowers PT on ...

    Benzinga
  21. Synageva Prices 2.15M Share Public Offering at $47.53/Share

    Benzinga
  22. UPDATE: Piper Jaffray Downgrades Synageva to Neutral on Lack ...

    Benzinga
  23. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  24. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  25. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  26. UPDATE: Wedbush Securities Reiterates Outperform Rating, Raises ...

    Benzinga
  27. Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)

    Benzinga
  28. Benzinga's Top Initiations

    Benzinga
  29. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  30. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  31. Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)

    Benzinga
  32. Synageva BioPharma Corp. (GEVA) SVP, CFO Carsten Boess sells ...

    GuruFocus
  33. Merck &, Quest Diagnostics Among Stocks Setting 52-Week Highs ...

    FoxBusiness
  34. Synageva BioPharma, WesBanco Hit 52-week Highs Wednesday

    FoxBusiness
  35. Synageva BioPharma, Deltek Hit 52-week Highs Tuesday

    FoxBusiness
  36. ASML, Wolverine World Wide Included in Stocks Up on High Volume ...

    FoxBusiness
  37. Synageva BioPharma Announces $80 Million Proposed Public Offering ...

    Benzinga
  38. Four Winning Trades Based on Analyst Calls

    Benzinga
  39. CF Industries Holdings, SBA Communications Corporation Included ...

    FoxBusiness
  40. Winning Trades Based on Analyst Ratings for June 25

    Benzinga
  41. Synageva BioPharma Jumps on Canaccord Genuity Initiation

    Benzinga
  42. Quest Software, Pharmacyclics, Other Stocks Hit 52-Week Highs ...

    FoxBusiness
  43. UPDATE: Canaccord Genuity Initiates Synageva BioPharma at BUy, ...

    Benzinga
  44. Synageva BioPharma Corp. (GEVA) President & CEO Sanj K Patel ...

    GuruFocus
  45. Synageva BioPharma Announces Interim Data at 8th Annual Lysosomal ...

    Benzinga
Trading Center